Tissue Engineering Is Fastest Growing Segment Fueling The Growth Of Stem Cell Manufacturing Market
The global Stem Cell Manufacturing Market is estimated to be valued at US$ 12415.84 Mn in 2023 and is expected to exhibit a CAGR of 13.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Stem cell manufacturing involves production of stem cells through various
processes such as cell isolation, cryopreservation and cell packaging. The
increasing research and development activities for treatment of various chronic
diseases and disorders such as cancer, cardiovascular diseases, diabetes among
others through stem cell and tissue engineering applications is driving the
growth of the stem cell manufacturing market.
Market key trends:
One of the key trends driving the growth of stem cell manufacturing market is
increasing research activities for development of personalized medicine.
Several research institutes and pharmaceutical companies have started focusing
on development and production of patient-specific stem cell products which can
cure chronic diseases more effectively with lesser side effects by considering
individual genetic variations. This is expected to boost the demand for stem
cell manufacturing over the forecast period.
Segment
Analysis
The global stem cell manufacturing market is segmented into tools, cell lines,
culture media, and other consumables. The cell lines segment currently
dominates the market as they provide unrestricted access to stem cells for
research and therapeutic applications. This segment is expected to continue its
dominance over the forecast period owing to the ability of cell lines to expand
indefinitely and their widespread adoption in developing novel cell-based
therapies.
Key Takeaways
The Global
Stem Cell Manufacturing Market Size is expected to witness high growth,
exhibiting a CAGR of 13.3% over the
forecast period, due to increasing incidence of chronic diseases and growing
demand for regenerative medicines.
Regional analysis
North America is expected to dominate the global stem cell manufacturing market
over the forecast period. This is attributed to the presence of advanced
healthcare infrastructure, higher healthcare spending, increasing stem cell
research activities, and supportive regulatory environment in the region. Asia
Pacific is anticipated to exhibit the fastest growth during the forecast period
owing to rising medical tourism, growing geriatric population, and improving
healthcare infrastructure.
Key players
Key players operating in the stem cell manufacturing market are TAKARA BIO
Inc., PHARMICELL Co., Ltd., MEDIPOST Co., Holostem Terapie Avanzate S.r.l,
Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith
& Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.),
Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and
Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics
Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell
Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and
Cellular Dynamics (Fujifilm Holdings Corporation, among others.
Read
More: https://www.ukwebwire.com/stem-cell-manufacturing-market-size-share-and-growth-forecast-2023-2023/
Comments
Post a Comment